SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRER14A - Preliminary Proxy Soliciting materials:
SEC Accession No. 0000882104-20-000096
Filing Date
2020-06-30
Accepted
2020-06-30 17:02:57
Documents
10

Document Format Files

Seq Description Document Type Size
1 PRER14A pdli-20200629prer14adoc.htm PRER14A 1609612
2 a2020proxycard063020a.jpg GRAPHIC 96788
3 a2020proxycard063020b.jpg GRAPHIC 129451
4 a2020proxycard063020c.jpg GRAPHIC 36914
5 a2020proxycard063020d.jpg GRAPHIC 255772
6 a2020proxychart2a02.jpg GRAPHIC 34788
7 dmsignaturea03.jpg GRAPHIC 11435
8 gcsiga07.gif GRAPHIC 2504
9 pdllogoa40.jpg GRAPHIC 123123
10 totalstockholderreturna03.jpg GRAPHIC 47772
  Complete submission text file 0000882104-20-000096.txt   2596065
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRER14A | Act: 34 | File No.: 000-19756 | Film No.: 201002945
SIC: 2836 Biological Products, (No Diagnostic Substances)